期刊文献+

莫索尼定对麻醉大鼠血流动力学的影响

Effects of moxonidine on hemodynamics in anesthetized rats
暂未订购
导出
摘要 目的观察国产盐酸莫索尼定对麻醉大鼠血流动力学的影响。方法采用麻醉Wistar大鼠动脉插管法,测定其血流动力学指标。结果给药后,HR、SBP轻度下降(P>0.05);DBP明显下降(P<0.01)的同时,±dp/dtmax,tdp/dtmax、Vpm及Vmax明显降低(P<0.01),且呈剂量依赖性。结论莫索尼定对心肌收缩性与舒张性均有明显的抑制作用;其降压作用与外周阻力下降有关。 Aim To investigate effects of moxonidine on hemodynamics in anesthetized rats. Methods The indexes of hemodynamics were examined by catheterization of arteries in anesthetized Wistar rats. Results DBP, + dp/dtmax,- dp/dtmax, t-dp/dtmax Vpm and Vmax were significantly declined in dose-dependent manner after administration, but HR and SBP didn't change significantly. Conclusion These resultsshowed that antihypertensive effects of moxonidine were related to inhibition of systolic and diastolic functions of myocardium. Furthermore, the antihypertensive effects of moxonidine were associated with reduction of peripheral vascular resistance.
出处 《中国药理学通报》 CAS CSCD 北大核心 2005年第8期1010-1013,共4页 Chinese Pharmacological Bulletin
基金 江苏省科技攻关资助项目(NoBE96049)
关键词 莫索尼定 血压 血流动力学 可乐定 moxonidine blood pressure hemodynamics clonidine
  • 相关文献

参考文献10

  • 1王化洲,金英,张云芳,路德泽.槐胺碱对心肌收缩性和麻醉犬血流动力学的影响[J].中国药理学通报,1995,11(3):224-227. 被引量:8
  • 2张树平,王建波,王巧云,田春林.不同剂量异丙酚对大鼠血流动力学的影响[J].中国药理学通报,1996,12(2):191-192. 被引量:2
  • 3Prichard BNC. Pharmacology and clinical use of moxonidine, a new centrally acting simpatholytic antihyperlensive agen [ J ]. J Human Hyper, 1997,11 (1) :29 -45.
  • 4Prichard B. The use of moxonidine in the treatment of hypertension [J]. J Hyper,1997,15(1):47-56.
  • 5Ernsberger P. Pharmacology of moxonidine: An-imidazoline receptor agonist[ J ]. J Cardiova.scular Pharmacol, 2000,35 ( 1 ) : 27 -41.
  • 6刘修鑫,陈连璧,马卫红,李莉,李艳,刘克静,刘兆平.卡维地洛对麻醉犬血流动力学的影响[J].中国药理学通报,1999,15(6):554-556. 被引量:1
  • 7Csete K,Papp G. Effects of moxonidine on coticocerbral blood flow under normal and ischemic conditions in conscious rabbits[ J]. J Cardiovascular Pharmacol, 2000,35(3 ) :417 -21.
  • 8Swedbery K, Bristow M,Cohn JN et al. Effects of sustained-release moxonidine, an imidazoline agonist,on plasma norepinephrine in patients with chronic heart failure[ J ]. J Am Heart Associ, 2002,105 ( 15 ) : 1797 - 803.
  • 9Uonend O, Marsalek P, Russ H et al, Moxonidine treatment of hypertensivepatient with advanced renal failure[ J ]. J Hyper, 2003,21(9) : 1709 - 17.
  • 10Ernsberger P. The I-imidazoline receptor from binding site to therapeutic target in cardiovascular disease [ J ], J Hyper 1997,15(1):9-25.

二级参考文献2

  • 1Yue T L,Hypertension,1993年,22卷,9期,2208页
  • 2Luigi X C,Clin Pharmacol Ther,1987年,41卷,1期,31页

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部